You have 9 free searches left this month | to do more

magrolimab

Magrolimab is a drug used to treat Acute Myeloid Leukemia, Solid Tumor, B-Cell Lymphoma, and other conditions. Magrolimab is being actively studied in 13 studies and prior, has been studied in 2.

Top SponsorsTop SitesTop Investigators
Gilead SciencesPrincess Alexandra HospitalSabine Mueller, MD, PhD
M.D. Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
National Cancer Institute (NCI)Astera Cancer Care
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Not yet recruiting
  • Acute Myeloid Leukemia
  • Magrolimab
  • +3 more
  • Houston, Texas
    MD Anderson Cancer Center
2022-02-03
Feb 3, 2022
U
Not yet recruiting
  • Brain Cancer
  • +5 more
  • Magrolimab
  • San Francisco, California
  • +1 more
2022-03-21
Mar 21, 2022
G
Active, not recruiting
  • Multiple Myeloma
  • Magrolimab
  • +5 more
  • Tucson, Arizona
  • +6 more
2022-03-30
Mar 30, 2022
N
Suspended
  • Follicular Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
S
Not yet recruiting
  • Hodgkin Lymphoma
  • +3 more
  • Magrolimab
  • +2 more
  • Stanford, California
    Stanford University
2021-08-16
Aug 16, 2021
G
Recruiting
  • Solid Tumor
  • Santa Rosa, California
  • +10 more
2022-03-21
Mar 21, 2022
M
Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-16
Nov 16, 2021
G
Recruiting
  • Myeloid Malignancies
  • Magrolimab
  • +6 more
  • Birmingham, Alabama
  • +12 more
2022-04-06
Apr 6, 2022
G
Recruiting
  • Triple-Negative Breast Cancer
  • Magrolimab
  • +3 more
  • Santa Rosa, California
  • +11 more
2022-03-30
Mar 30, 2022
G
Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Magrolimab
  • +6 more
  • Palo Alto, California
  • +13 more
2022-03-24
Mar 24, 2022
G
Active, not recruiting
  • Hematological Malignancies
  • Duarte, California
  • +26 more
2022-02-03
Feb 3, 2022
G
G
Active, not recruiting
  • Non Hodgkin Lymphoma
  • Magrolimab
  • +3 more
  • Birmingham, Alabama
  • +19 more
2022-01-04
Jan 4, 2022
G
Active, not recruiting
  • Myelodysplastic Syndromes
  • Magrolimab
  • +2 more
  • Birmingham, Alabama
  • +153 more
2022-02-03
Feb 3, 2022